COVID-19 pandemic

• 1. Introduction

  ›

  On the 31st of December 2019, the World Health Organization's office in China received a notification about a cluster of pneumonia cases of unknown origin in Wuhan. No one yet had a name for what was spreading. Within weeks, scientists would identify a novel coronavirus. Within months, it would reach every corner of the planet. The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 -- SARS-CoV-2 -- would become the fifth-deadliest pandemic or epidemic in recorded history. It would trigger the largest global recession since the Great Depression, kill tens of millions of people, and permanently alter how the world works, travels, and governs itself. How did a cluster of pneumonia cases in a single Chinese city become a global catastrophe? And how did humanity fight back?

• 2. The Wuhan Outbreak

  ›

  Zhang Jixian, a Chinese pulmonologist, was the first to observe and act on what would become a defining cluster. She treated an unusual pneumonia group on the 26th of December 2019, and two days later alerted the Wuhan Jianghan CDC. On the 28th of December, a genetic sequencing company named Vision Medicals reported the discovery of a novel coronavirus to China's national disease authority. The evidence was beginning to accumulate. Yet the early response was tangled by misdirection. A test report from CapitalBio Medlab, addressed to the Wuhan Central Hospital, mistakenly returned a positive result for the original SARS virus. Doctors who raised alarms were punished for it. Eight of them, including ophthalmologist Li Wenliang, who was born in 1985 and died in 2020, were detained by police on the 3rd of January for what authorities called "spreading false rumours". The number of confirmed cases in Hubei had reached at least 266 by the 31st of December 2019. Molecular clock analysis suggests the first human cases may have occurred as early as October or November of that year, weeks before Zhang Jixian's cluster. The virus was circulating silently before anyone knew to look.

• 3. A Virus Goes Global

  ›

  On the 30th of January 2020, with 7,818 infections confirmed worldwide, the WHO declared a public health emergency of international concern. The virus was already on the move. By late January, it had spread through other Chinese provinces, carried partly by the mass movement of people during Chinese New Year. Wuhan's role as a major rail interchange accelerated that spread. Italy became the first country to record a national lockdown after two Chinese tourists tested positive in Rome on the 31st of January. By the 19th of March, Italy had overtaken China in reported deaths. By the 26th of March, the United States had surpassed both China and Italy in confirmed infections. Genomic analysis revealed that most of New York's early infections originated from Europe, not directly from Asia. A retrospective test later found a person in France infected as early as the 27th of December 2019, and another in the United States who died of the disease on the 6th of February 2020. COVID-19 arrived in many places before it was detected. By October 2020, the WHO estimated that one in ten people worldwide -- roughly 780 million -- may have been infected, even as only 35 million cases had been confirmed.

• 4. The Toll of the Disease

  ›

  The infection fatality ratio for COVID-19 varied by a factor of roughly 10,000 across age groups. For people aged 0-34, the estimated IFR was 0.004%. For those aged 85 and older, it reached 28.3%. The time between symptom onset and death ranged from 6 to 41 days, typically about 14 days. Common symptoms included fever, cough, fatigue, and loss of taste and smell; that last combination was reported in as many as 88 percent of confirmed cases. Between 5 percent and 50 percent of patients later developed long COVID, with fatigue and memory problems among the most commonly reported lasting effects. Official death counts consistently underrepresented the true toll. By the 25th of January 2024, The Economist estimated between 18.5 and 35.2 million deaths attributable to the pandemic worldwide. The WHO's own excess mortality analysis found roughly 14.9 million more deaths than expected by the end of 2021, compared with 5.4 million reported COVID-19 deaths at the time. Some of those unreported deaths came from people who could not access medical care for other conditions. COVID-19 also reshaped life expectancy in the United States. From 2019 to 2020, life expectancy dropped by 3 years for Hispanic Americans, 2.9 years for African Americans, and 1.2 years for white Americans.

• 5. Vaccines and the Race for Immunity

  ›

  On the 9th of November 2020, Pfizer released trial results showing a 90 percent effectiveness in preventing infection. On the 2nd of December 2020, the United Kingdom became the first developed country to approve the Pfizer vaccine; 800,000 doses were immediately available. Vaccine deployment began in many countries that same month. By August 2024, more than 5.6 billion people had received at least one dose, with 13.7 billion doses administered in total. The Oxford-AstraZeneca vaccine was the most widely used globally. A June 2022 study estimated that COVID-19 vaccines prevented between 14.4 and 19.8 million deaths across 185 countries during the first year of rollout alone. But distribution was profoundly unequal. By April 2021, one in 500 people in low and middle-income countries had been vaccinated, against one in four in high-income countries. COVAX, co-led by the WHO, GAVI, and the Coalition for Epidemic Preparedness Innovations, was designed to address that gap. Herd immunity proved elusive: in July 2021, experts raised concern that the Delta variant could transmit even among vaccinated individuals, leading the WHO and CDC to continue recommending masking and distancing for vaccinated people. In 2022, the first inhalable vaccine was developed by Chinese biopharmaceutical company CanSino Biologics.

• 6. Variants and Shifting Science

  ›

  Alpha, first detected in the UK's southeast in December 2020, showed changes to the spike protein that made it more infectious. By the 2nd of January 2021, it had been identified in 33 countries. Delta, first identified in India, spread to the UK by mid-April 2021 and within two months had driven a full third wave, forcing the government to delay reopening that had been scheduled for June. Omicron was detected in South Africa on the 24th of November 2021; the WHO declared it a variant of concern within days. On the 1st of January 2022, Europe passed 100 million cases amid an Omicron surge. Sub-lineages of Omicron, designated BA.1 through BA.5, were each assessed as separate variants of concern before being downgraded in March 2023. By May 2023, the WHO had downgraded all variants of concern, noting they were no longer detected in new infections. The naming of variants had itself required careful management. The WHO adopted Greek letters to replace geographic identifiers -- Delta had originally been called the Indian variant -- partly to prevent social stigma. The naming convention switched to a more systematic lineage code for later variants; Omicron's lineage is B.1.1.529.

• 7. Economies, Societies, and Supply Chains

  ›

  On the 27th of February 2020, US stock indexes posted their sharpest single-day falls since 2008, as pandemic fears reached financial markets. By the first week of April 2020, 3.9 billion people -- more than half the world's population -- were under some form of lockdown. The pandemic caused the largest global recession since the Great Depression. Retailers in Europe and Latin America reported foot traffic declines of 40 percent; North American and Middle Eastern retailers saw drops of 50 to 60 percent. More than 40 million jobs were lost in the United States alone. The International Labour Organization reported that income from work across the world dropped 10.7 percent -- equivalent to $3.5 trillion -- in the first nine months of 2020. Personal protective equipment shortages were acute: according to WHO Director-General Tedros Ghebreyesus, demand rose one hundredfold and prices climbed twentyfold. Supply chain disruptions touched nearly every sector. In May 2026, the US charged seven Chinese executives and four major container manufacturers with conspiring to restrict shipping container production and fix prices from 2019 to 2024, actions that contributed to global supply chain disruptions during the pandemic. A 2021 UNESCO report estimated ten million job losses in the culture and creative industries worldwide. By contrast, white-collar telework expanded sharply, and the pandemic drove widespread adoption of telehealth.

• 8. The End of the Emergency

  ›

  On the 5th of May 2023, WHO Director-General Tedros -- having convened with the International Health Regulations Emergency Committee -- downgraded COVID-19 from a global health emergency, reclassifying it as an "established and ongoing health issue". The committee cited the decline in deaths and hospitalisations, the prevalence of vaccinations, and the level of general immunity. In a press conference, Tedros said the diminishing threat had "allowed most countries to return to life as we knew it before COVID-19". On the 3rd of December 2022, the WHO had reported that at least 90 percent of the world's population had some level of immunity to SARS-CoV-2. By 2025, experts generally believed the pandemic had transitioned into the endemic phase, though Time reported in March 2024 that expert opinions still differed on whether COVID-19 was currently endemic or pandemic. The disease had not disappeared; it continued to circulate. Different academic fields, different locations, and different social groups applied different criteria for declaring an epidemic's end, reflecting the WHO's own position that such ends are as much social phenomena as biological ones. Nature reported in 2021 that 90 percent of researchers surveyed believed the coronavirus would become endemic -- a status that, unlike eradication, means living alongside a pathogen rather than eliminating it.